PublisherDOIYearVolumeIssuePageTitleAuthor(s)Link
Environmental Health and Toxicology10.5620/eht.e20180022017331e2018002Use of adverse outcome pathways in chemical toxicity testing: potential advantages and limitationsJaeseong Jeong, Jinhee Choihttp://e-eht.org/upload/pdf/eht-33-1-e2018002.pdf, http://e-eht.org/journal/view.php?doi=10.5620/eht.e2018002, http://e-eht.org/upload/pdf/eht-33-1-e2018002.pdf
Journal of Dentistry10.1016/0300-5712(94)90032-9199422S6-S11Use of cell cultures for toxicity testing of dental materials—advantages and limitationsG. Schmalzhttps://api.elsevier.com/content/article/PII:0300571294900329?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:0300571294900329?httpAccept=text/plain
Archives of Toxicology10.1007/s00204-012-0974-4201287113-14Stress response pathways, toxicity pathways and adverse outcome pathwaysPaul Jenningshttp://link.springer.com/content/pdf/10.1007/s00204-012-0974-4.pdf, http://link.springer.com/article/10.1007/s00204-012-0974-4/fulltext.html, http://link.springer.com/content/pdf/10.1007/s00204-012-0974-4
In Silico Methods for Predicting Drug Toxicity10.1007/978-1-0716-1960-5_202022521-535Adverse Outcome Pathways as Versatile Tools in Liver Toxicity TestingEmma Arnesdotter, Eva Gijbels, Bruna dos Santos Rodrigues, Vânia Vilas-Boas, Mathieu Vinkenhttps://link.springer.com/content/pdf/10.1007/978-1-0716-1960-5_20
Toxicology Letters10.1016/s0378-4274(21)00412-42021350S70Adverse outcome pathways for uranium induced kidney toxicityY. Guéguenhttps://api.elsevier.com/content/article/PII:S0378427421004124?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S0378427421004124?httpAccept=text/plain
A Systems Biology Approach to Advancing Adverse Outcome Pathways for Risk Assessment10.1007/978-3-319-66084-4_102018199-218Use of Genetic Manipulation for Evaluating and Understanding Adverse Outcome PathwaysChristopher Warner, Natàlia Garcia-Reyero, Edward Perkinshttp://link.springer.com/content/pdf/10.1007/978-3-319-66084-4_10
A Systems Biology Approach to Advancing Adverse Outcome Pathways for Risk Assessment10.1007/978-3-319-66084-4_172018349-378Use of Adverse Outcome Pathways in Human Risk Assessment and ToxicologyCatherine Willett, Suzanne Fitzpatrick, Bette Meek, Carl Westmorelandhttp://link.springer.com/content/pdf/10.1007/978-3-319-66084-4_17
Reproductive Toxicology10.1016/j.reprotox.2014.07.01220144816Introduction: Adverse Outcome Pathways – Future for DART testingManon Beekhuijzenhttps://api.elsevier.com/content/article/PII:S0890623814001221?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S0890623814001221?httpAccept=text/plain
Alternatives to Animal Testing10.1007/978-981-13-2447-5_11201883-90The Use of Adverse Outcome Pathways (AOPs) to Support Chemical Safety Decisions Within the Context of Integrated Approaches to Testing and Assessment (IATA)Catherine Willetthttp://link.springer.com/content/pdf/10.1007/978-981-13-2447-5_11
In Silico Methods for Predicting Drug Toxicity10.1007/978-1-4939-3609-0_142016325-337Adverse Outcome Pathways as Tools to Assess Drug-Induced ToxicityMathieu Vinkenhttp://link.springer.com/content/pdf/10.1007/978-1-4939-3609-0_14